RDMD
The platform lets patients with rare diseases access their medical data and participate in research studies.
Also: RDMD names Spark Capital's Nabeel Hyatt to the board of directors, Unite US announces next COO.
Also: RDMD locks in $14M for rare disease therapy research; VIDA Diagnostics raises $11M for AI lunch imaging analysis.
RDMD, a Bay Area startup leveraging personal health records to accelerate clinical research of rare diseases, has raised $3 million in seed funding.